Welcome to the Merck (Vioxx) Securities Litigation Website
This website has been established for a class action lawsuit that is now pending in the United States District Court for the District of New Jersey against (i) Merck & Co., Inc. ("Merck"); and (ii) Dr. Edward Scolnick (the former President of Merck Research Laboratories) and Dr. Alise Reicin (the former Executive Director of Clinical Research at Merck Research Laboratories) (collectively, the “Individual Defendants” and, together with Merck, the “Defendants”). The Action has been certified by the Court to proceed as a class action on behalf of the Class.
The “Class,” as certified by the Court, consists of:
All persons and entities who, from May 21, 1999 to September 29, 2004, inclusive (the “Class Period”), purchased or otherwise acquired Merck & Co., Inc. (“Merck”) common stock or call options, or sold Merck put options (the “Class”).
Excluded from the Class by definition are:
(a) Defendants; (b) Merck’s affiliates and subsidiaries; (c) the officers and directors of Merck and its subsidiaries and affiliates at all relevant times; (d) members of the immediate family of any excluded person; (e) the legal representatives, heirs, successors, and assigns of any excluded person or entity; and (f) any entity in which any excluded person or entity has or had a controlling interest.
If you are a member of the Class, your rights will be affected by this Action. It is important that you read the Notice of Pendency of Class Action, which explains your rights and deadlines that apply to Class Members. If you do not meet the Class definition, the Notice does not apply to you. If you are uncertain whether you are a member of the Class, contact Class Counsel, or your own attorney. Please note that Class Counsel and the Notice Administrator do not have access to information about your transactions in Merck common stock or options.